
See exactly how FPHAX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FPHAX and 80,000+ other tickers.
This fund typically allocates a minimum of 80% of its capital to entities involved in the pharmaceutical sector, encompassing activities from scientific discovery and development to manufacturing and distribution of various medicinal products. Its holdings include both domestic and international companies, with the portfolio primarily consisting of common equities. Investment decisions are guided by a thorough fundamental analysis, assessing aspects like a company's financial health, its standing within the industry, and broader market and economic trends. It operates as a non-diversified portfolio.
No recent news available.